Endothelin antagonists in hypertension and kidney disease. - Wikidata - awgldk - TriplyDB

Endothelin antagonists in hypertension and kidney disease.

Endothelin antagonists in hypertension and kidney disease.

http://www.wikidata.org/entity/Q38052428

about

Inhibition of ENaC by endothelin-1 The paradox of bardoxolone methyl: a call for every witness on the stand?Cellular mechanisms of tissue fibrosis. 8. Current and future drug targets in fibrosis: focus on Rho GTPase-regulated gene transcription.Hypertension Management in Diabetic Kidney Disease Mice, double deficient in lysosomal serine carboxypeptidases Scpep1 and Cathepsin A develop the hyperproliferative vesicular corneal dystrophy and hypertrophic skin thickenings.Nanomedicines for Endothelial Disorders.Serum Concentrations of Endothelin-1 and Matrix Metalloproteinases-2, -9 in Pre-Hypertensive and Hypertensive Patients with Type 2 Diabetes Signaling between tumor cells and the host bone marrow microenvironment.Plasma endothelin-1 levels in patients with resistant hypertension: effects of renal sympathetic denervation.Efficacy and Safety of Sparsentan Compared With Irbesartan in Patients With Primary Focal Segmental Glomerulosclerosis: Randomized, Controlled Trial Design (DUET).Differential ERK1/2 Signaling and Hypertrophic Response to Endothelin-1 in Cardiomyocytes from SHR and Wistar-Kyoto Rats: A Potential Target for Combination Therapy of Hypertension.

P2860

Q27005957-7F54DAB1-CD67-40A5-B9C8-586F80FFDCEC Q33358784-77FAA4D8-6336-44A1-91D4-CE956D22976E Q33840143-AD255479-DAF9-4B7E-B2D6-59E0FC60A47F Q35953909-0E3EBD6F-4747-4DD3-9F87-B12ACCEEC266 Q36289890-E5D72A26-5438-4BBC-9F69-95D388744C85 Q36651592-D417221A-59E3-4CEF-B00D-CB0241119D72 Q37209809-30521682-EE6D-4E43-8A17-67C4877D4FCC Q38138849-F726F07D-483D-4D02-9702-15D66F180332 Q39022728-446FBAEA-33BD-4610-BEB4-225F7D32CD19 Q46399341-E8AA9EE3-940C-403F-83AF-27C0412DEA76 Q54312226-976AE906-7205-4759-88FA-ABCC74BA27DC

P2860

Endothelin antagonists in hypertension and kidney disease.

http://www.wikidata.org/entity/Q38052428

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Endothelin antagonists in hypertension and kidney disease.

@en

type

label

Endothelin antagonists in hypertension and kidney disease.

@en

prefLabel

Endothelin antagonists in hypertension and kidney disease.

@en

P1433

Q38052428-43E9FE55-7046-474B-BBB9-E58892911C5C

P1476

Q38052428-DAA73F8C-253D-4881-915E-EE6F8FEF388B

P2093

Q38052428-2C1F7246-01AD-4DD0-8B12-D08688BD97EA

Q38052428-6B2C59C2-0DBF-4773-8A44-D6A63CCF7710

P2860

Q38052428-1017C1FB-3992-49DC-A1ED-AEB018077669

Q38052428-12A25605-D8B1-48C5-8E7E-2E2C660B0BE7

Q38052428-16C80A53-31A2-4E16-BC83-AFDE0CC6BDE2

Q38052428-187E7A9B-BF54-468B-A37C-5CC3DFBDA1A8

Q38052428-202202AA-729D-47A2-83B3-DCDAF97F5758

Q38052428-243D9721-F54D-4DB2-8B7B-507A7ED3FE31

Q38052428-2455DED0-858A-4C29-9CB6-A78C1FFFA213

Q38052428-26CD4016-F96E-447C-959A-D01173ADED14

Q38052428-2B18FB83-899F-4AAC-B20F-FBBBA77A005D

Q38052428-2C2B38AD-2272-4BFD-A4F9-97FFA2DC2507

P2888

Q38052428-624A174E-C316-41C7-BE06-3A3B3DB992A6

P304

Q38052428-D6291FC6-6E95-40B7-8DA0-901C252608B9

P31

Q38052428-0EBB238C-282B-4910-9EA2-FCA2A5E6D629

P356

Q38052428-60DCEACF-089C-411E-8E49-B8FAD1B95089

P433

Q38052428-682A52CA-6BCF-4875-A1DC-578A062C258B

P478

Q38052428-F9B40BC2-4DF2-46C7-98F5-3711B8B2AE63

P577

Q38052428-B2E3D547-C146-4641-85CA-46E263AE7B82

P6179

Q38052428-ED8162A9-7537-4AC6-9E20-5AF30AA08BB7

P698

Q38052428-74F2B7B3-C8DC-4A6C-B080-BEBBBD28D802

P921

Q38052428-9FA840FD-5809-4F1E-B616-895A17A87F45

P356

S00467-012-2316-4

P1433

Pediatric Nephrology

P1476

Endothelin antagonists in hypertension and kidney disease.

@en

P2093

Christine Sethna

http://www.w3.org/2001/XMLSchema#string

Kevin E C Meyers

http://www.w3.org/2001/XMLSchema#string

P2860

ECE-1: a membrane-bound metalloprotease that catalyzes the proteolytic activation of big endothelin-1

Avosentan reduces albumin excretion in diabetics with macroalbuminuria

Role of endothelin in cardiovascular disease

Organization of the gene encoding the human endothelin-converting enzyme (ECE-1)

The gene for the novel vasoactive peptide endothelin 3 (EDN3) is localized to human chromosome 20q13.2-qter

Disruption of ECE-1 and ECE-2 reveals a role for endothelin-converting enzyme-2 in murine cardiac development

Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor

Diabetic state, high plasma insulin and angiotensin II combine to augment endothelin-1-induced vasoconstriction via ETA receptors and ERK

A novel potent vasoconstrictor peptide produced by vascular endothelial cells

Avosentan for overt diabetic nephropathy.

P2888

s00467-012-2316-4

P304

711-720

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00467-012-2316-4

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

28

http://www.w3.org/2001/XMLSchema#string

P577

2012-10-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1023845450

http://www.w3.org/2001/XMLSchema#string

P698

23070275

http://www.w3.org/2001/XMLSchema#string

P921

arterial hypertension